Disruption of the nuclear p53-GAPDH complex protects against ischemia-induced neuronal damage

Molecular Brain

Volumn 7, Issue 1, 2014, Pages

  Zhai, Dongxu ^a   Chin, Kyle ^a   Wang, Min ^a   Liu, Fang ^a,b  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMPA RECEPTOR; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; PROTEIN P53; UBIQUITIN PROTEIN LIGASE E3;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DAMAGE; BRAIN ISCHEMIA; CELL DEATH; CELL NUCLEUS; COMPLEX FORMATION; CONTROLLED STUDY; HIPPOCAMPUS; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVE CELL CULTURE; NERVE INJURY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RAT; SURVIVAL TIME; T LYMPHOCYTE; UPREGULATION;

ANIMALS; BRAIN ISCHEMIA; CELL DEATH; CELL NUCLEUS; CYTOPROTECTION; DISEASE MODELS, ANIMAL; GLUTAMIC ACID; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; HEK293 CELLS; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; KAINIC ACID; NEURONS; NEUROPROTECTIVE AGENTS; NUCLEAR PROTEINS; PROTEIN BINDING; PROTEIN TRANSPORT; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, AMPA; RECOMBINANT FUSION PROTEINS; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITIN-PROTEIN LIGASES;

EID: 84898405493     PISSN: None     EISSN: 17566606     Source Type: Journal    
DOI: 10.1186/1756-6606-7-20     Document Type: Article

References (64)

1. Glyceraldehyde-3-phosphate dehydrogenase: nuclear translocation participates in neuronal and nonneuronal cell death. Sawa A, Khan AA, Hester LD, Snyder SH, Proc Natl Acad Sci U S A 1997 94 11669 11674 10.1073/pnas.94.21. 11669 9326668 (Pubitemid 27451056)
2. Nuclear localization of overexpressed glyceraldehyde-3-phosphate dehydrogenase in cultured cerebellar neurons undergoing apoptosis. Ishitani R, Tanaka M, Sunaga K, Katsube N, Chuang DM, Mol Pharmacol 1998 53 701 707 9547361 (Pubitemid 28196493)
3. Glyceraldehyde-3-phosphate dehydrogenase antisense oligodeoxynucleotides protect against cytosine arabinonucleoside-induced apoptosis in cultured cerebellar neurons. Ishitani R, Chuang DM, Proc Natl Acad Sci U S A 1996 93 9937 9941 10.1073/pnas.93.18.9937 8790435 (Pubitemid 26296713)
4. S-nitrosylated GAPDH initiates apoptotic cell death by nuclear translocation following Siah1 binding. Hara MR, Agrawal N, Kim SF, Cascio MB, Fujimuro M, Ozeki Y, Takahashi M, Cheah JH, Tankou SK, Hester LD, Ferris CD, Hayward SD, Snyder SH, Sawa A, Nat Cell Biol 2005 7 665 674 10.1038/ncb1268 15951807 (Pubitemid 40975747)
5. A porcine brain protein (35 K protein) which bundles microtubules and its identification as glyceraldehyde 3-phosphate dehydrogenase. Kumagai H, Sakai H, J Biochem 1983 93 1259 1269 6885722
6. Tubulin is the endogenous inhibitor of the glyceraldehyde 3-phosphate dehydrogenase isoform that catalyzes membrane fusion: Implications for the coordinated regulation of glycolysis and membrane fusion. Glaser PE, Han X, Gross RW, Proc Natl Acad Sci U S A 2002 99 14104 14109 10.1073/pnas.222542999 12381782 (Pubitemid 35257632)
7. Glyceraldehyde-3-phosphate dehydrogenase in the extracellular space inhibits cell spreading. Yamaji R, Chatani E, Harada N, Sugimoto K, Inui H, Nakano Y, Biochim Biophys Acta 2005 1726 261 271 10.1016/j.bbagen.2005.07.013 16125849 (Pubitemid 41668534)
8. Glyceraldehyde-3-phosphate dehydrogenase selectively binds AU-rich RNA in the NAD (+)-binding region (Rossmann fold). Nagy E, Rigby WF, J Biol Chem 1995 270 2755 2763 10.1074/jbc.270.6.2755 7531693
9. Specific interaction of glyceraldehyde 3-phosphate dehydrogenase with the 5'-nontranslated RNA of hepatitis A virus. Schultz DE, Hardin CC, Lemon SM, J Biol Chem 1996 271 14134 14142 10.1074/jbc.271.24.14134 8662893 (Pubitemid 26190309)
10. Glyceraldehyde-3-phosphate dehydrogenase is required for vesicular transport in the early secretory pathway. Tisdale EJ, J Biol Chem 2001 276 2480 2486 10.1074/jbc.M007567200 11035021
11. Glyceraldehyde-3-phosphate dehydrogenase is phosphorylated by protein kinase ciota /lambda and plays a role in microtubule dynamics in the early secretory pathway. Tisdale EJ, J Biol Chem 2002 277 3334 3341 10.1074/jbc.M109744200 11724794 (Pubitemid 34953200)
12. Glyceraldehyde-3-phosphate dehydrogenase interacts with Rab2 and plays an essential role in endoplasmic reticulum to golgi transport exclusive of its glycolytic activity. Tisdale EJ, Kelly C, Artalejo CR, J Biol Chem 2004 279 54046 54052 10.1074/jbc.M409472200 15485821 (Pubitemid 40053138)
13. Studies on a mammalian cell protein (P8) with affinity for DNA in vitro. Tsai RL, Green H, J Mol Biol 1973 73 307 316 10.1016/0022-2836(73)90344-6 4686197
14. Sequence-specific binding of transfer RNA by glyceraldehyde-3-phosphate dehydrogenase. Singh R, Green MR, Science 1993 259 365 368 10.1126/science. 8420004 8420004 (Pubitemid 23055678)
15. Uracil DNA-glycosylase/glyceraldehyde-3-phosphate dehydrogenase is an Ap4A binding protein. Baxi MD, Vishwanatha JK, Biochemistry 1995 34 9700 9707 10.1021/bi00030a007 7626640
16. Direct interaction between GluR2 and GAPDH regulates AMPAR-mediated excitotoxicity. Wang M, Li S, Zhang H, Pei L, Zou S, Lee FJ, Wang YT, Liu F, Mol Brain 2012 5 13 10.1186/1756-6606-5-13 22537872
17. GOSPEL: a neuroprotective protein that binds to GAPDH upon S-nitrosylation. Sen N, Hara MR, Ahmad AS, Cascio MB, Kamiya A, Ehmsen JT, Agrawal N, Hester L, Dore S, Snyder SH, Sawa A, Neuron 2009 63 81 91 10.1016/j.neuron.2009.05.024 19607794
18. AIRE-induced apoptosis is associated with nuclear translocation of stress sensor protein GAPDH. Liiv I, Haljasorg U, Kisand K, Maslovskaja J, Laan M, Peterson P, Biochem Biophys Res Commun 2012 423 32 37 10.1016/j.bbrc.2012.05.057 22613203
19. SIRT1 interacts with and protects glyceraldehyde-3-phosphate dehydrogenase (GAPDH) from nuclear translocation: implications for cell survival after irradiation. Joo HY, Woo SR, Shen YN, Yun MY, Shin HJ, Park ER, Kim SH, Park JE, Ju YJ, Hong SH, Hwang SG, Cho MH, Kim J, Lee KH, Biochem Biophys Res Commun 2012 424 681 686 10.1016/j.bbrc.2012.07.006 22789853
20. UCP2 inhibition triggers ROS-dependent nuclear translocation of GAPDH and autophagic cell death in pancreatic adenocarcinoma cells. Dando I, Fiorini C, Pozza ED, Padroni C, Costanzo C, Palmieri M, Donadelli M, Biochim Biophys Acta 1833 2013 672 679
21. CIB1 prevents nuclear GAPDH accumulation and non-apoptotic tumor cell death via AKT and ERK signaling. Leisner TM, Moran C, Holly SP, Parise LV, Oncogene 2012 32 4017 4027 22964641
22. p53 is not necessary for nuclear translocation of GAPDH during NO-induced apoptosis. Kim JJ, Lee MY, BMB Rep 2011 44 782 786 10.5483/BMBRep.2011.44.12. 782 22189680
23. Nitric oxide-induced nuclear GAPDH activates p300/CBP and mediates apoptosis. Sen N, Hara MR, Kornberg MD, Cascio MB, Bae BI, Shahani N, Thomas B, Dawson TM, Dawson VL, Snyder SH, Sawa A, Nat Cell Biol 2008 10 866 873 10.1038/ncb1747 18552833 (Pubitemid 351934066)
24. In vivo protein transduction: delivery of a biologically active protein into the mouse. Schwarze SR, Ho A, Vocero-Akbani A, Dowdy SF, Science 1999 285 1569 1572 10.1126/science.285.5433.1569 10477521 (Pubitemid 29420581)
25. Treatment of ischemic brain damage by perturbing NMDA receptor- PSD-95 protein interactions. Aarts M, Liu Y, Liu L, Besshoh S, Arundine M, Gurd JW, Wang YT, Salter MW, Tymianski M, Science 2002 298 846 850 10.1126/science. 1072873 12399596 (Pubitemid 35231541)
26. Uncoupling the dopamine D1-D2 receptor complex exerts antidepressant-like effects. Pei L, Li S, Wang M, Diwan M, Anisman H, Fletcher PJ, Nobrega JN, Liu F, Nature medicine 2010 16 1393 1395 10.1038/nm.2263 21113156
27. The alpha7nACh-NMDA receptor complex is involved in cue-induced reinstatement of nicotine seeking. Li S, Li Z, Pei L, Le AD, Liu F, J Exp Med 2012 209 2141 2147 10.1084/jem.20121270 23091164
28. Dual regulation of NMDA receptor functions by direct protein-protein interactions with the dopamine D1 receptor. Lee FJ, Xue S, Pei L, Vukusic B, Chery N, Wang Y, Wang YT, Niznik HB, Yu XM, Liu F, Cell 2002 111 219 230 10.1016/S0092-8674(02)00962-5 12408866 (Pubitemid 35292442)
29. Direct protein-protein coupling enables cross-talk between dopamine D5 and gamma-aminobutyric acid A receptors. Liu F, Wan Q, Pristupa ZB, Yu XM, Wang YT, Niznik HB, Nature 2000 403 274 280 10.1038/35002014 10659839 (Pubitemid 30062376)
30. Protein-protein coupling/uncoupling enables dopamine D2 receptor regulation of AMPA receptor-mediated excitotoxicity. Zou S, Li L, Pei L, Vukusic B, Van Tol HH, Lee FJ, Wan Q, Liu F, J Neurosci 2005 25 4385 4395 10.1523/JNEUROSCI.5099-04.2005 15858065 (Pubitemid 40628783)
31. NMDA receptor subunits have differential roles in mediating excitotoxic neuronal death both in vitro and in vivo. Liu Y, Wong TP, Aarts M, Rooyakkers A, Liu L, Lai TW, Wu DC, Lu J, Tymianski M, Craig AM, Wang YT, J Neurosci 2007 27 2846 2857 10.1523/JNEUROSCI.0116-07.2007 17360906 (Pubitemid 46438991)
32. Effectiveness of PSD95 inhibitors in permanent and transient focal ischemia in the rat. Sun HS, Doucette TA, Liu Y, Fang Y, Teves L, Aarts M, Ryan CL, Bernard PB, Lau A, Forder JP, Salter MW, Wang YT, Tasker RA, Tymianski M, Stroke 2008 39 2544 2553 10.1161/STROKEAHA.107.506048 18617669
33. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL, Bartkowski H, Stroke 1986 17 472 476 10.1161/01.STR.17.3.472 3715945 (Pubitemid 16085691)
34. Photochemical stroke model: flunarizine prevents sensorimotor deficits after neocortical infarcts in rats. De Ryck M, Van Reempts J, Borgers M, Wauquier A, Janssen PA, Stroke 1989 20 1383 1390 10.1161/01.STR.20.10.1383 2799870 (Pubitemid 19254555)
35. Disruption of the GluR2/GAPDH complex protects against ischemia-induced neuronal damage. Zhai D, Li S, Wang M, Chin K, Liu F, Neurobiol Dis 2013
36. DAPK1 interaction with NMDA receptor NR2B subunits mediates brain damage in stroke. Tu W, Xu X, Peng L, Zhong X, Zhang W, Soundarapandian MM, Balel C, Wang M, Jia N, Zhang W, Lew F, Chan SL, Chen Y, Lu Y, Cell 2010 140 222 234 10.1016/j.cell.2009.12.055 20141836
37. Blockade of calcium-permeable AMPA receptors protects hippocampal neurons against global ischemia-induced death. Noh KM, Yokota H, Mashiko T, Castillo PE, Zukin RS, Bennett MV, Proc Natl Acad Sci U S A 2005 102 12230 12235 10.1073/pnas.0505408102 16093311 (Pubitemid 41291157)
38. Expression of Ca (2+)-permeable AMPA receptor channels primes cell death in transient forebrain ischemia. Liu S, Lau L, Wei J, Zhu D, Zou S, Sun HS, Fu Y, Liu F, Lu Y, Neuron 2004 43 43 55 10.1016/j.neuron.2004.06.017 15233916 (Pubitemid 38952818)
39. Neuroprotection by pharmacologic blockade of the GAPDH death cascade. Hara MR, Thomas B, Cascio MB, Bae BI, Hester LD, Dawson VL, Dawson TM, Sawa A, Snyder SH, Proc Natl Acad Sci U S A 2006 103 3887 3889 10.1073/pnas.0511321103 16505364 (Pubitemid 43376650)
40. Seven in absentia, a gene required for specification of R7 cell fate in the drosophila eye. Carthew RW, Rubin GM, Cell 1990 63 561 577 10.1016/0092-8674(90)90452-K 2146028 (Pubitemid 20374101)
41. Neuronal life and death: an essential role for the p53 family. Miller FD, Pozniak CD, Walsh GS, Cell Death Differ 2000 7 880 888 10.1038/sj.cdd.4400736 11279533
42. Possible role of NF-kappaB and p53 in the glutamate-induced pro-apoptotic neuronal pathway. Grilli M, Memo M, Cell Death Differ 1999 6 22 27 10.1038/sj.cdd.4400463 10200544 (Pubitemid 29051851)
43. Nitric oxide and neuronal death. Brown GC, Nitric Oxide 2010 23 153 165 10.1016/j.niox.2010.06.001 20547235
44. A synthetic inhibitor of p53 protects neurons against death induced by ischemic and excitotoxic insults, and amyloid beta-peptide. Culmsee C, Zhu X, Yu QS, Chan SL, Camandola S, Guo Z, Greig NH, Mattson MP, J Neurochem 2001 77 220 228 10.1046/j.1471-4159.2001.t01-1-00220.x 11279278 (Pubitemid 32245096)
45. Neurons are protected from excitotoxic death by p53 antisense oligonucleotides delivered in anionic liposomes. Lakkaraju A, Dubinsky JM, Low WC, Rahman YE, J Biol Chem 2001 276 32000 32007 10.1074/jbc.M100138200 11406618
46. p53 induction is associated with neuronal damage in the central nervous system. Sakhi S, Bruce A, Sun N, Tocco G, Baudry M, Schreiber SS, Proc Natl Acad Sci U S A 1994 91 7525 7529 10.1073/pnas.91.16.7525 8052613 (Pubitemid 24238217)
47. Induction of tumour-suppressor phosphoprotein p53 in the apoptosis of cultured rat cerebellar neurones triggered by excitatory amino acids. Uberti D, Belloni M, Grilli M, Spano P, Memo M, Eur J Neurosci 1998 10 246 254 10.1046/j.1460-9568.1998.00042.x 9753133 (Pubitemid 28325446)
48. Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis. D'Orazi G, Cecchinelli B, Bruno T, Manni I, Higashimoto Y, Saito S, Gostissa M, Coen S, Marchetti A, Del Sal G, Piaggio G, Fanciulli M, Appella E, Soddu S, Nat Cell Biol 2002 4 11 19 10.1038/ncb714 11780126 (Pubitemid 34071975)
49. Regulation of p53 activity by its interaction with homeodomain- interacting protein kinase-2. Hofmann TG, Moller A, Sirma H, Zentgraf H, Taya Y, Droge W, Will H, Schmitz ML, Nat Cell Biol 2002 4 1 10 10.1038/ncb715 11740489 (Pubitemid 34071974)
50. A DNA damage-induced p53 serine 392 kinase complex contains CK2, hSpt16, and SSRP1. Keller DM, Zeng X, Wang Y, Zhang QH, Kapoor M, Shu H, Goodman R, Lozano G, Zhao Y, Lu H, Mol Cell 2001 7 283 292 10.1016/S1097-2765(01)00176-9 11239457 (Pubitemid 32206496)
51. p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53. Oda K, Arakawa H, Tanaka T, Matsuda K, Tanikawa C, Mori T, Nishimori H, Tamai K, Tokino T, Nakamura Y, Taya Y, Cell 2000 102 849 862 10.1016/S0092-8674(00)00073-8 11030628
52. Calcium-permeable AMPA channels in neurodegenerative disease and ischemia. Kwak S, Weiss JH, Curr Opin Neurobiol 2006 16 281 287 10.1016/j.conb.2006.05.004 16698262 (Pubitemid 43949226)
53. Ischemic insults direct glutamate receptor subunit 2-lacking AMPA receptors to synaptic sites. Liu B, Liao M, Mielke JG, Ning K, Chen Y, Li L, El-Hayek YH, Gomez E, Zukin RS, Fehlings MG, Wan Q, J Neurosci 2006 26 5309 5319 10.1523/JNEUROSCI.0567-06.2006 16707783 (Pubitemid 44318383)
54. RAGE expression is up-regulated in human cerebral ischemia and pMCAO rats. Zhai DX, Kong QF, Xu WS, Bai SS, Peng HS, Zhao K, Li GZ, Wang DD, Sun B, Wang JH, Wang GY, Li HL, Neurosci Lett 2008 445 117 121 10.1016/j.neulet.2008. 08.077 18782604
55. Beneficial effects of alpha-lipoic acid plus vitamin E on neurological deficit, reactive gliosis and neuronal remodeling in the penumbra of the ischemic rat brain. Gonzalez-Perez O, Gonzalez-Castaneda RE, Huerta M, Luquin S, Gomez-Pinedo U, Sanchez-Almaraz E, Navarro-Ruiz A, Garcia-Estrada J, Neurosci Lett 2002 321 100 104 10.1016/S0304-3940(02)00056-3 11872266 (Pubitemid 34185508)
56. Reduction of CuZn-superoxide dismutase activity exacerbates neuronal cell injury and edema formation after transient focal cerebral ischemia. Kondo T, Reaume AG, Huang TT, Carlson E, Murakami K, Chen SF, Hoffman EK, Scott RW, Epstein CJ, Chan PH, J Neurosci 1997 17 4180 4189 9151735 (Pubitemid 27220609)
57. Nitric oxide-GAPDH-Siah: a novel cell death cascade. Hara MR, Snyder SH, Cell Mol Neurobiol 2006 26 527 538 16633896
58. Nuclear translocation and overexpression of GAPDH by the hyper-pressure in retinal ganglion cell. Kim CI, Lee SH, Seong GJ, Kim YH, Lee MY, Biochem Biophys Res Commun 2006 341 1237 1243 10.1016/j.bbrc.2006.01.087 16469296 (Pubitemid 43221797)
59. Involvement of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and p53 in neuronal apoptosis: evidence that GAPDH is upregulated by p53. Chen RW, Saunders PA, Wei H, Li Z, Seth P, Chuang DM, J Neurosci 1999 19 9654 9662 10531467 (Pubitemid 30228116)
60. Potential role of nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase in apoptosis and oxidative stress. Dastoor Z, Dreyer JL, J Cell Sci 2001 114 1643 1653 11309196 (Pubitemid 32454663)
61. Cell signaling and neuronal death. Hara MR, Snyder SH, Annu Rev Pharmacol Toxicol 2007 47 117 141 10.1146/annurev.pharmtox.47.120505.105311 16879082
62. p53 potentiates hippocampal neuronal death caused by global ischemia. Yonekura I, Takai K, Asai A, Kawahara N, Kirino T, J Cereb Blood Flow Metab 2006 26 1332 1340 10.1038/sj.jcbfm.9600293 16538233 (Pubitemid 44435247)
63. Attenuation of p53 expression protects against focal ischemic damage in transgenic mice. Crumrine RC, Thomas AL, Morgan PF, J Cereb Blood Flow Metab 1994 14 887 891 10.1038/jcbfm.1994.119 7929653 (Pubitemid 24332932)
64. Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation. Brooks CL, Gu W, Curr Opin Cell Biol 2003 15 164 171 10.1016/S0955-0674(03)00003-6 12648672 (Pubitemid 36332191)